In a consensus statement issued by the Harmonizing Outcome Measures for Eczema (HOME) Clinical Practice initiative and published online Oct. 12 in JAMA Dermatology , instruments are identified for measuring eczema control and itch intensity in patients with atopic eczema.

Yael A. Leshem, M.D., from Rabin Medical Center in Petah-Tikva, Israel, and colleagues identified instruments to measure eczema control and itch intensity through systematic reviews informing a consensus process. To optimize instrument selection for clinical practice, feasibility aspects were highlighted. If fewer than 30 percent of the voters disagreed, consensus on an instrument was reached.

The researchers found that of the seven instruments identified, the Recap of Atopic Eczema and Atopic Dermatitis Control Tool were recommended for measuring eczema control (5 and 10 percent of voters disagreed, respectively). Support was garnered for a single-question patient global assessment, but consensus was not reached. Three of the six available itch-intensity instruments were recommended by consensus: a peak 24-hour numeric rating scale (NRS)-itch and one-week NRS-itch instruments from the Patient-Reported Outcomes Measurement Information System Itch Questionnaire, measuring average and peak itch (17, 22, and 27 percent of voters disagreed, respectively).

"The HOME Eczema Clinical Practice set is a 'pick and choose' list of well-validated, feasible-to-use instruments that clinicians can use in their daily practice," the authors write. "These instruments can supplement, not replace, the thorough interpersonal medical encounter."

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)